Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Krystal Biotech (KRYS) Other Operating Expenses: 2023-2025

Historic Other Operating Expenses for Krystal Biotech (KRYS) over the last 2 years, with Sep 2025 value amounting to $4.3 million.

  • Krystal Biotech's Other Operating Expenses fell 36.22% to $4.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $21.4 million, marking a year-over-year increase of 19.03%. This contributed to the annual value of $20.1 million for FY2024, which is 79.94% down from last year.
  • Per Krystal Biotech's latest filing, its Other Operating Expenses stood at $4.3 million for Q3 2025, which was down 40.50% from $7.2 million recorded in Q2 2025.
  • Krystal Biotech's 5-year Other Operating Expenses high stood at $100.0 million for Q3 2023, and its period low was $2.4 million during Q1 2024.
  • Moreover, its 3-year median value for Other Operating Expenses was $5.0 million (2025), whereas its average is $15.5 million.
  • Per our database at Business Quant, Krystal Biotech's Other Operating Expenses plummeted by 93.32% in 2024 and then surged by 107.85% in 2025.
  • Over the past 3 years, Krystal Biotech's Other Operating Expenses (Quarterly) stood at $2.9 million in 2023, then surged by 72.38% to $4.9 million in 2024, then crashed by 36.22% to $4.3 million in 2025.
  • Its last three reported values are $4.3 million in Q3 2025, $7.2 million for Q2 2025, and $5.0 million during Q1 2025.